Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Assets (2016 - 2025)

Lisata Therapeutics' Non-Current Assets history spans 13 years, with the latest figure at $41000.0 for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 90.33% year-over-year to $41000.0; the TTM value through Dec 2025 reached $864000.0, down 60.82%, while the annual FY2025 figure was $41000.0, 90.33% down from the prior year.
  • Non-Current Assets reached $41000.0 in Q4 2025 per LSTA's latest filing, down from $184000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.0 million in Q1 2023 to a low of $41000.0 in Q4 2025.
  • Average Non-Current Assets over 3 years is $555416.7, with a median of $550000.0 recorded in 2024.
  • Peak YoY movement for Non-Current Assets: plummeted 33.75% in 2024, then tumbled 90.33% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $770000.0 in 2023, then crashed by 44.94% to $424000.0 in 2024, then crashed by 90.33% to $41000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Non-Current Assets are $41000.0 (Q4 2025), $184000.0 (Q3 2025), and $275000.0 (Q2 2025).